Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients.

• Type of Material: Article
• Authors: Alton Farris III, Emory University; Carla Ellis, Emory University; Thomas Rogers, Emory University; W. James Chon, University of Chicago; Anthony Chang, University of Chicago; Shane M. Meehan, University of Chicago
• Language: English
• Date: 2017-04
• Publisher: Oxford University Press
• Publication Version: Final Published Version
• Copyright Statement: © The Author 2017
• License: Creative Commons Attribution-NonCommercial 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1093/ckj/sfw117
• Title of Journal or Parent Work: Clinical Kidney Journal
• ISSN: 2048-8505
• Volume: 10
• Issue: 2
• Start Page: 240
• End Page: 248
• Grant/Funding Information: The study has no source of funding.
• Keywords: histopathology; kidney; transplant; urinary tract infection; nephritis
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

Background: Granulomatous interstitial nephritis (GIN) is uncommon in native kidneys, and descriptions in allografts are few. We report clinical and pathologic findings in 22 allograft recipients with GIN identified in renal allograft biopsies and nephrectomies. Methods: Renal allografts with GIN were retrieved from the pathology files of two academic medical centers. Available clinical and pathologic data were compiled retrospectively for a 23-year period. Results: GIN was present in 23 specimens from 22 patients (15 males and 7 females) with allograft dysfunction [serum creatinine averaged 3.3 mg/dL (range 1.4-7.8)], at a mean age of 48 years (range 22-77). GIN was identified in 0.3% of biopsies at a mean of 552 days post transplantation (range 10-5898). GIN was due to viral (5), bacterial (5) and fungal (2) infections in 12 (54.5%), and drug exposure was the likely cause in 5 cases (22.7%). One had recurrent granulomatosis with polyangiitis. In 4 cases, no firm etiology of GIN was established. Of 18 patients with follow up data, 33.3% had a complete response to therapy, 44.5% had a partial response and 22.2% developed graft loss due to fungal and E. coli infections. All responders had graft survival for more than 1 year after diagnosis of GIN. Conclusions: Allograft GIN is associated with a spectrum of etiologic agents and was identified in 0.3% of biopsies. Graft failure occurred in 22% of this series, due to fungal and bacterial GIN; however, most had complete or partial dysfunction reversal and long-term graft survival after appropriate therapy.